-
ANRO Dashboard
- Financials
- Filings
-
Holdings
-
Transcripts
- ETFs
- Insider
- Institutional
- Shorts
Alto Neuroscience (ANRO)
Company Profile
Quarter (USD) | Sep 24 | Jun 24 | Mar 24 | Dec 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 23 | |
---|---|---|
Revenue | ||
Cost of revenue | ||
Operating income | ||
Operating margin | ||
Net income | ||
Net profit margin | ||
Cash on hand | ||
Change in cash | ||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 182.20 mm | 182.20 mm | 182.20 mm | 182.20 mm | 182.20 mm | |
Cash burn (monthly) | 3.81 mm | 1.97 mm | 6.30 mm | 4.30 mm | 915.25 k | |
Cash used (since last report) | 15.32 mm | 7.95 mm | 25.34 mm | 17.31 mm | 3.68 mm | |
Cash remaining | 166.88 mm | 174.25 mm | 156.87 mm | 164.89 mm | 178.52 mm | |
Runway (months of cash) | 43.8 | 88.3 | 24.9 | 38.3 | 195.0 |
13F holders | Current |
---|---|
Total holders | 82 |
Opened positions | 30 |
Closed positions | 5 |
Increased positions | 34 |
Reduced positions | 9 |
13F shares | Current |
---|---|
Total value | 241.24 bn |
Total shares | 22.82 mm |
Total puts | 616.40 k |
Total calls | 984.30 k |
Total put/call ratio | 0.6 |
Largest owners | Shares | Value |
---|---|---|
Falcon Edge Capital | 3.71 mm | $42.42 bn |
FMR | 2.36 mm | $27.03 bn |
Ra Capital Management | 2.08 mm | $23.74 bn |
BlackRock | 1.45 mm | $16.54 bn |
Vanguard | 1.27 mm | $14.57 bn |
BEN Franklin Resources | 1.22 mm | $16.98 bn |
ExodusPoint Capital Management | 1.16 mm | $13.30 mm |
Point72 Asset Management | 977.69 k | $11.18 bn |
Alkeon Capital Management | 934.90 k | $10.70 bn |
Jennison Associates | 832.29 k | $9.52 bn |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
2 Jan 25 | Husseini Manji | Stock Option Common Stock | Grant | Acquire A | No | No | 3.17 | 14,195 | 45.00 k | 14,195 |
2 Jan 25 | Gwill York | Stock Option Common Stock | Grant | Acquire A | No | No | 3.17 | 19,558 | 62.00 k | 19,558 |
2 Jan 25 | Christopher Nixon Cox | Stock Option Common Stock | Grant | Acquire A | No | No | 3.17 | 25,236 | 80.00 k | 25,236 |
10 Jul 24 | Adam Savitz | Common Stock | Buy | Acquire P | Yes | No | 13.22 | 2,931 | 38.75 k | 39,851 |
9 Jul 24 | Adam Savitz | Common Stock | Buy | Acquire P | Yes | No | 13.15 | 1,388 | 18.25 k | 36,920 |
9 Jul 24 | Adam Savitz | Common Stock | Buy | Acquire P | Yes | No | 12.53 | 10,681 | 133.83 k | 35,532 |
20 May 24 | Jr. Michael Conick Hanley | Employee Stock Option Common Stock | Grant | Acquire A | No | No | 12.4 | 188,000 | 2.33 mm | 188,000 |